[RGLS] YoY Quarter Result on 31-Dec-2012 [#Q4]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
19-Feb-2013
Financial Year
2012
Quarter
31-Dec-2012 [#Q4]
Profit Trend
QoQ- -20.95%
YoY- -241.24%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 18 18 10,860 4,219 5,454 3,238 3,363 -58.14%
PBT -14,506 -20,015 -7,222 -22,168 -1,946 -6,858 -1,940 39.79%
Tax -58 5 4 -1 -19 18 75 -
NP -14,448 -20,020 -7,226 -22,168 -1,927 -6,876 -2,015 38.82%
Tax Rate - - - - - - - -
Total Cost 14,466 20,038 18,086 26,387 7,381 10,114 5,378 17.91%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin -80,266.67 -111,222.22 -66.54 -525.43 -35.33 -212.35 -59.92 231.65%
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
EPS -16.68 -45.39 -16.52 -56.76 -5.53 -23.03 -2,704.70 -57.14%
EPS Diluted -16.68 -45.39 -16.52 -56.76 -5.35 -23.00 -2,704.70 -57.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.